Cost-effectiveness evaluation of amphotericin B, amphotericin B liposomal, caspofungin and voriconazol in treating aspergillosis under the brazilian private health care system perspective.

Related Articles

Cost-effectiveness evaluation of amphotericin B, amphotericin B liposomal, caspofungin and voriconazol in treating aspergillosis under the brazilian private health care system perspective.

Value Health. 2013 May;16(3):A91

Authors: Fujii RK, Manfrin DF, Lanzara GD, Hájek P, Mould J

PMID: 23694629 [PubMed - in process]

Deja un comentario

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.